David Rosen – HRTX history
- Issuer:
- HERON THERAPEUTICS INC
- Quarters tracked:
- 16 (Q3 2022 → Q2 2026)
- Current shares:
- 30,046,828
- Current value:
- $12.82M
- Peak shares:
- 30,046,828 (Q4 2025)
- Overall change:
- +1094%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q2 2026 | 30,046,828 | $12.82M | $0.43 | 0 | 0% |
| Q1 2026 | 30,046,828 | $24.04M | $0.80 | 0 | 0% |
| Q4 2025 | 30,046,828 | $39.06M | $1.30 | +946,100 | +3% |
| Q3 2025 | 29,100,728 | $36.67M | $1.26 | +2,387,225 | +9% |
| Q2 2025 | 26,713,503 | $55.30M | $2.07 | 0 | 0% |
| Q1 2025 | 26,713,503 | $58.77M | $2.20 | 0 | 0% |
| Q4 2024 | 26,713,503 | $40.87M | $1.53 | 0 | 0% |
| Q3 2024 | 26,713,503 | $53.16M | $1.99 | 0 | 0% |
| Q2 2024 | 26,713,503 | $93.50M | $3.50 | 0 | 0% |
| Q1 2024 | 26,713,503 | $74.00M | $2.77 | 0 | 0% |
| Q4 2023 | 26,713,503 | $45.41M | $1.70 | 0 | 0% |
| Q3 2023 | 26,713,503 | $27.52M | $1.03 | +14,963,503 | +127% |
| Q2 2023 | 11,750,000 | $13.63M | $1.16 | 0 | 0% |
| Q1 2023 | 11,750,000 | $17.74M | $1.51 | 0 | 0% |
| Q4 2022 | 11,750,000 | $29.38M | $2.50 | +9,233,672 | +367% |
| Q3 2022 | 2,516,328 | $10.62M | $4.22 | — | NEW |